Header Logo

Connection

ALASTAIR THOMPSON to In Situ Hybridization, Fluorescence

Back to Details
This is a "connection" page, showing publications ALASTAIR THOMPSON has written about In Situ Hybridization, Fluorescence.
ALASTAIR THOMPSON
Connection Strength
0.252
In Situ Hybridization, Fluorescence
  1. Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS). Breast Cancer Res. 2010; 12(6):R92.
    View in: PubMed
    Score: 0.064
  2. Increased mortality in HER2 positive, oestrogen receptor positive invasive breast cancer: a population-based study. Br J Cancer. 2010 Aug 10; 103(4):475-81.
    View in: PubMed
    Score: 0.063
  3. High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer. Int J Cancer. 2010 Jul 15; 127(2):355-60.
    View in: PubMed
    Score: 0.063
  4. HER2 assessment on core biopsy specimens using monoclonal antibody CB11 accurately determines HER2 status in breast carcinoma. Histopathology. 2010 May; 56(6):702-7.
    View in: PubMed
    Score: 0.062
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.